Chao-Fu Wang
Shanghai Jiao Tong University
15 Papers
74 Citations
Chao-Fu Wang is an academic researcher from Shanghai Jiao Tong University. The author has contributed to research in topics: Medicine & Diffuse large B-cell lymphoma. The author has an hindex of 4, co-authored 14 publications.
Chat about Author
Papers
Genomic and Transcriptomic Characterization of Natural Killer T Cell Lymphoma
Jie Xiong,Bowen Cui,Nan Wang,Yuting Dai,Hao Zhang,Chao-Fu Wang,Hui-Juan Zhong,Shu Cheng,Bin-Shen Ou-Yang,Yu Hu,Xi Zhang,Bin Xu,Wen-Bin Qian,Rong Tao,Feng Yan,Jianda Hu,Ming Hou,Xue-Jun Ma,Xin Wang,Yuan-Hua Liu,Zunmin Zhu,Xiao-Bin Huang,Li Liu,Chong-Yang Wu,Li Huang,Yun-Feng Shen,Ruibin Huang,Jingyan Xu,Chun Wang,Depei Wu,Li Yu,Jianfeng Li,Pengpeng Xu,Li Wang,Jinyan Huang,Sai-Juan Chen,Wei-Li Zhao +36 more
TL;DR: Three prominent subtypes of NKTCL are defined, which differ significantly in cell of origin, EBV gene expression, transcriptional signatures, and responses to asparaginase-based regimens and targeted therapy.
198
Butyrate-producing Eubacterium rectale suppresses lymphomagenesis by alleviating the TNF-induced TLR4/MyD88/NF-κB axis.
Haiyang Lu,Xiaoqiang Xu,Di Fu,Yubei Gu,Rong Fan,Hongmei Yi,Xiangyi He,Chao-Fu Wang,Binshen Ouyang,Ping Zhao,Li Wang,Pengpeng Xu,Shu Cheng,Zhifeng Wang,Duo-Wu Zou,Lizhong Han,Wei-Li Zhao +16 more
TL;DR: In this article , the authors performed metagenomic sequencing on human primary gastrointestinal B cell lymphomas and identified a distinct microbiota profile of intestinal lymphoma, with significantly decreased symbiotic microbes, particularly the genus Eubacterium and notably butyrate-producing Eubacteriaium rectale.
92
A Phase II Study of Methotrexate, Etoposide, Dexamethasone and Pegaspargase Sandwiched with Radiotherapy in the Treatment of Newly Diagnosed, Stage IE to IIE Extranodal Natural-Killer/T-Cell Lymphoma, Nasal-Type.
P P Xu,Jie Xiong,Shu Cheng,Xia Zhao,Chao-Fu Wang,Gang Cai,Hui Juan Zhong,Heng Ye Huang,Jiayi Chen,Zhao Wl +9 more
TL;DR: MESA sandwiched with radiotherapy is an effective and safe regimen for early-stage ENKTL and asparaginase-associated metabolic score (AspM) may be a promising prognostic index of serum metabolites in addition to clinical prognostic Index in ENK TL.
48
Clinical efficacy and molecular biomarkers in a phase II study of tucidinostat plus R-CHOP in elderly patients with newly diagnosed diffuse large B-cell lymphoma
Mu-Chen Zhang,Ying Fang,Li Wang,Shu Cheng,Di Fu,Yang He,Yan Zhao,Chao-Fu Wang,Xu-Feng Jiang,Qi Song,Pengpeng Xu,Wei-Li Zhao +11 more
TL;DR: Relevance of DEL phenotype and molecular biomarkers on CR-CHOP response warrants further investigation in DLBCL, and the 2-year PFS and OS rates of double-expressor lymphoma phenotype (DEL) were improved, and negative prognostic effect of histone acetyltransferases CREBBP / EP300 mutations was also mitigated by CR- CHOP.
JAM-A overexpression is related to disease progression in diffuse large B-cell lymphoma and downregulated by lenalidomide.
Pengpeng Xu,Yifeng Sun,Ying Fang,Qi Song,Zi-Xun Yan,Yi Chen,Xu-Feng Jiang,Xiaochun Fei,Yan Zhao,Christophe Leboeuf,Christophe Leboeuf,Biao Li,Chao-Fu Wang,Anne Janin,Anne Janin,Li Wang,Wei-Li Zhao +16 more
TL;DR: It is shown that junctional adhesion molecule-A (JAM-A) was highly expressed in DLBCL patients with multiple extranodal lesions and identified as a biomarker of stem cell property, which indicated the sensitivity of B-lymphoma cells to lenalidomide.
24